Annual Report — Form 10-K Filing Table of Contents
Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 2.55M
2: EX-4.11 Instrument Defining the Rights of Security Holders HTML 164K
3: EX-10.32 Material Contract HTML 67K
4: EX-10.33 Material Contract HTML 42K
5: EX-10.34 Material Contract HTML 43K
6: EX-10.35 Material Contract HTML 89K
7: EX-10.36 Material Contract HTML 52K
8: EX-10.37 Material Contract HTML 53K
9: EX-21.2 Subsidiaries List HTML 40K
10: EX-23.1 Consent of Expert or Counsel HTML 39K
11: EX-31.1 Certification -- §302 - SOA'02 HTML 43K
12: EX-31.2 Certification -- §302 - SOA'02 HTML 43K
13: EX-32.1 Certification -- §906 - SOA'02 HTML 40K
14: EX-32.2 Certification -- §906 - SOA'02 HTML 40K
21: R1 Document and Entity Information HTML 108K
22: R2 Consolidated Balance Sheets HTML 120K
23: R3 Consolidated Balance Sheets (Parentheticals) HTML 78K
24: R4 Consolidated Statements of Operations HTML 118K
25: R5 Consolidated Statements of Comprehensive Income HTML 63K
(Loss)
26: R6 Consolidated Statements of Changes in HTML 81K
Stockholders' Equity
27: R7 Consolidated Statements of Changes in HTML 40K
Stockholders' Equity (Parentheticals)
28: R8 Consolidated Statements of Cash Flows HTML 181K
29: R9 Significant Accounting Policies HTML 85K
30: R10 Fair Values of Financial Instruments HTML 175K
31: R11 Investments HTML 326K
32: R12 Mortgage Loans on Real Estate HTML 275K
33: R13 Derivative Instruments HTML 112K
34: R14 Deferred Policy Acquisition Costs, Deferred Sales HTML 88K
Inducements and Liability for Lifetime Income
Benefit Riders
35: R15 Reinsurance and Policy Provisions HTML 70K
36: R16 Income Taxes HTML 99K
37: R17 Notes Payable and Amounts Due Under Repurchase HTML 53K
Agreements
38: R18 Subordinated Debentures HTML 59K
39: R19 Retirement and Share-based Compensation Plans HTML 108K
40: R20 Statutory Financial Information and Dividend HTML 56K
Restrictions
41: R21 Commitments and Contingencies HTML 47K
42: R22 Earnings Per Common Share and Stockholders' Equity HTML 64K
43: R23 Quarterly Financial Information (Unaudited) HTML 87K
44: R24 Schedule I - Summary of Investments - Other Than HTML 66K
Investments in Related Parties
45: R25 Schedule II - Condensed Financial Information of HTML 162K
Registrant
46: R26 Schedule III - Supplementary Insurance Information HTML 67K
47: R27 Schedule IV - Reinsurance HTML 87K
48: R28 Schedule V - Valuation and Qualifying Accounts HTML 62K
49: R29 Significant Accounting Policies (Policies) HTML 149K
50: R30 Significant Accounting Policies (Tables) HTML 51K
51: R31 Fair Values of Financial Instruments (Tables) HTML 154K
52: R32 Investments (Tables) HTML 333K
53: R33 Mortgage Loans on Real Estate (Tables) HTML 268K
54: R34 Derivative Instruments (Tables) HTML 113K
55: R35 Deferred Policy Acquisition Costs, Deferred Sales HTML 84K
Inducements and Liability for Lifetime Income
Benefit Riders (Tables)
56: R36 Reinsurance and Policy Provisions (Tables) HTML 61K
57: R37 Income Taxes (Tables) HTML 101K
58: R38 Notes Payable and Amounts Due Under Repurchase HTML 51K
Agreements (Tables)
59: R39 Subordinated Debentures (Tables) HTML 57K
60: R40 Retirement and Share-based Compensation Plans HTML 90K
(Tables)
61: R41 Statutory Financial Information and Dividend HTML 55K
Restrictions (Tables)
62: R42 Commitments and Contingencies (Tables) HTML 44K
63: R43 Earnings Per Common Share and Stockholders' Equity HTML 57K
(Tables)
64: R44 Quarterly Financial Information (Unaudited) HTML 87K
(Tables)
65: R45 Significant Accounting Policies (Narrative) HTML 75K
(Details)
66: R46 Significant Accounting Policies (Annuity Deposits HTML 59K
(Net of Coinsurance), By Product Type) (Details)
67: R47 Fair Values of Financial Instruments (Narrative) HTML 70K
(Details)
68: R48 Fair Values of Financial Instruments (Carrying HTML 79K
Amounts and Fair Values of Financial Instruments)
(Details)
69: R49 Fair Values of Financial Instruments (Assets and HTML 115K
Liabilities Measured on a Recurring Basis by Fair
Value Hierarchy) (Details)
70: R50 Fair Values of Financial Instruments (Assumptions HTML 77K
Used in Estimating Fair Value) (Details)
71: R51 Fair Values of Financial Instruments HTML 52K
(Reconciliation of Beginning and Ending Balances
of Level 3 Liabilities) (Details)
72: R52 Investments (Narrative) (Details) HTML 59K
73: R53 Investments (Schedule of Fixed Maturity HTML 94K
Securities) (Details)
74: R54 Investments (Fixed Maturity Securities by HTML 94K
Contractual Maturity) (Details)
75: R55 Investments (Net Unrealized Gains on Available for HTML 50K
Sale Fixed Maturity Securities Reported as a
Seperate Component of Stockholders' Equity)
(Details)
76: R56 Investments (Credit Quality of Fixed Maturity HTML 60K
Security Portfolio by NAIC Designation) (Details)
77: R57 Investments (Gross Unrealized Losses on HTML 124K
Investments, By Category and Length of Time)
(Details)
78: R58 Investments (Changes in Net Unrealized HTML 55K
Gains/Losses on Investments) (Details)
79: R59 Investments (Components of Net Investment Income) HTML 62K
(Details)
80: R60 Investments (Net Realized Gains (Losses) on HTML 82K
Invesments) (Details)
81: R61 Investments (Non-Income Producing Investments) HTML 41K
(Details)
82: R62 Investments (Rollforward of Allowance for Credit HTML 65K
Loss) (Details)
83: R63 Investments (Other Than Temporary Impairment, HTML 48K
Credit Losses Recognized in Earnings) (Details)
84: R64 Investments (Schedule of Other Than Temporary HTML 59K
Impairment Losses, Investments) (Details)
85: R65 Mortgage Loans on Real Estate (Narrative) HTML 72K
(Details)
86: R66 Mortgage Loans on Real Estate (Summary of Mortgage HTML 66K
Loan Portfolio) (Details)
87: R67 Mortgage Loans on Real Estate (Commercial Mortgage HTML 88K
Loan Portfolio Summarized by Geographic Region and
Property Type) (Details)
88: R68 Mortgage Loans on Real Estate (Rollforward of HTML 61K
Valuation Allowance on Mortgage Loan Portfolios)
(Details)
89: R69 Mortgage Loans on Real Estate (Summary By Debt HTML 131K
Service Coverage and Loan to Value Ratios)
(Details)
90: R70 Mortgage Loans on Real Estate (Aging of Financing HTML 113K
Receivables) (Details)
91: R71 Derivative Instruments (Narrative) (Details) HTML 48K
92: R72 Derivative Instruments (Fair Value of Derivative HTML 52K
Instruments as Presented in the Consolidated
Balance Sheets) (Details)
93: R73 Derivative Instruments (Change in Fair Value of HTML 55K
Derivative Instruments) (Details)
94: R74 Derivative Instruments (Schedule of Call Options HTML 74K
by Counterparty) (Details)
95: R75 Deferred Policy Acquisition Costs, Deferred Sales HTML 53K
Inducements and Liability for Lifetime Income
Benefit Riders (Deferred Policy Acquisition Costs)
(Details)
96: R76 Deferred Policy Acquisition Costs, Deferred Sales HTML 51K
Inducements and Liability for Lifetime Income
Benefit Riders (Deferred Sales Inducements)
(Details)
97: R77 Deferred Policy Acquisition Costs, Deferred Sales HTML 72K
Inducements and Liability for Lifetime Income
Benefit Riders (Liability for Lifetime Income
Benefit Riders) (Details)
98: R78 Reinsurance and Policy Provisions (EquiTrust HTML 56K
Coinsurance Agreements) (Details)
99: R79 Reinsurance and Policy Provisions (Athene HTML 73K
Coinsurance Agreements) (Details)
100: R80 Reinsurance and Policy Provisions (Amounts Ceded HTML 73K
to EquiTrust and Athene, Impact on Consolidated
Statements of Operations and Consolidated
Statements of Cash Flows) (Details)
101: R81 Reinsurance and Policy Provisions (Hannover HTML 54K
Financing Arrangements) (Details)
102: R82 Income Taxes (Components of Income Tax Expense) HTML 56K
(Details)
103: R83 Income Taxes (Effective Income Tax Rate HTML 67K
Reconciliation) (Details)
104: R84 Income Taxes (Deferred Tax Assets and Liabilities) HTML 93K
(Details)
105: R85 Notes Payable and Amounts Due Under Repurchase HTML 50K
Agreements (Schedule of Notes Payable) (Details)
106: R86 Notes Payable and Amounts Due Under Repurchase HTML 48K
Agreements (2027 Notes Narrative) (Details)
(Details)
107: R87 Notes Payable and Amounts Due Under Repurchase HTML 78K
Agreements (Line of Credit and Term Loan
Narrative) (Details)
108: R88 Notes Payable and Amounts Due Under Repurchase HTML 44K
Agreements (Repurchase Agreements Narrative)
(Details)
109: R89 Subordinated Debentures (Narrative) (Details) HTML 48K
110: R90 Subordinated Debentures (Summary of Subordinated HTML 61K
Debt Obligations to the Trusts) (Details)
111: R91 Retirement and Share-based Compensation Plans HTML 42K
(Defined Contribution Plan) (Details)
112: R92 Retirement and Share-based Compensation Plans HTML 48K
(Share-based Compensation Expense By Plan)
(Details)
113: R93 Retirement and Share-based Compensation Plans HTML 44K
(Employee Stock Ownership Plan) (Details)
114: R94 Retirement and Share-based Compensation Plans HTML 117K
(Incentive Plans) (Details)
115: R95 Retirement and Share-based Compensation Plans HTML 93K
(2014 Independent Insurance Agent Restricted Stock
and Restricted Stock Unit Plan) (Details)
116: R96 Retirement and Share-based Compensation Plans HTML 85K
(Changes in Stock Options Outstanding) (Details)
117: R97 Retirement and Share-based Compensation Plans HTML 90K
(Schedule of Stock Options Outstanding, By
Exercise Price Range) (Details)
118: R98 Retirement and Share-based Compensation Plans HTML 47K
(Deferred Compensation Arrangements) (Details)
119: R99 Statutory Financial Information and Dividend HTML 58K
Restrictions (Narrative and Statutory Accounting
Practices Tables) (Details)
120: R100 Commitments and Contingencies (Narrative and HTML 63K
Schedule of Future Minimum Rental Payments for
Operating Leases) (Details)
121: R101 Earnings Per Common Share and Stockholders' Equity HTML 72K
(Schedule of Earnings Per Common Share, Basic and
Diluted) (Details)
122: R102 Earnings Per Common Share and Stockholders' Equity HTML 61K
(Stockholders' Equity) (Details)
123: R103 Earnings Per Common Share and Stockholders' Equity HTML 56K
(Brookfield Asset Management Equity Investment)
(Details)
124: R104 Earnings Per Common Share and Stockholders' Equity HTML 65K
(Share Repurchase Program and Treasury Stock)
(Details)
125: R105 Quarterly Financial Information (Unaudited) HTML 69K
(Unaudited Quarterly Results of Operations)
(Details)
126: R106 Quarterly Financial Information (Unaudited) HTML 41K
(Comparability of Net Income, Impact of Fair Value
Accounting to Fixed Index Annuity Business)
(Details)
127: R107 Schedule I - Summary of Investments - Other Than HTML 82K
Investments in Related Parties (Details)
128: R108 Schedule II - Condensed Financial Information of HTML 112K
Registrant (Condensed Balance Sheets) (Details)
129: R109 Schedule II - Condensed Financial Information of HTML 106K
Registrant (Condensed Statements of Operations)
(Details)
130: R110 Schedule II - Condensed Financial Information of HTML 152K
Registrant (Condensed Statements of Cash Flows)
(Details)
131: R111 Schedule III - Supplementary Insurance Information HTML 59K
(Details)
132: R112 Schedule IV - Reinsurance (Details) HTML 76K
133: R113 Schedule V - Valuation and Qualifying Accounts HTML 60K
(Details)
135: XML IDEA XML File -- Filing Summary XML 269K
20: XML XBRL Instance -- ael-20201231_htm XML 6.20M
134: EXCEL IDEA Workbook of Financial Reports XLSX 212K
16: EX-101.CAL XBRL Calculations -- ael-20201231_cal XML 422K
17: EX-101.DEF XBRL Definitions -- ael-20201231_def XML 1.70M
18: EX-101.LAB XBRL Labels -- ael-20201231_lab XML 3.21M
19: EX-101.PRE XBRL Presentations -- ael-20201231_pre XML 2.06M
15: EX-101.SCH XBRL Schema -- ael-20201231 XSD 354K
136: JSON XBRL Instance as JSON Data -- MetaLinks 630± 1.05M
137: ZIP XBRL Zipped Folder -- 0001039828-21-000018-xbrl Zip 795K
THIS EMPLOYEE STOCK OPTION AGREEMENT, hereinafter referred to as the “Option” or the “Agreement,” is made effective as of ______________ (the “Date of Grant”), between American Equity Investment Life Holding Company (the “Company”) and ______________ (the “Optionee”).
The Company hereby grants an option of _______ shares of common stock of the
Company, $1.00 par value per share (“Stock”), to the Optionee at the price and in all respects subject to the terms, definitions and provisions of this Agreement, and the Amended and Restated Equity Incentive Plan, adopted by the Company effective June 4, 2020 (the “Plan”), the terms and definitions of which are incorporated herein, unless the context implies otherwise.
1.Option Price. The option price is _______ for each share, the price being at least 100% of the fair market value of a share of the Stock on the date of the grant of this Option.
2.Exercise of Option and Vesting Schedule. This
Option is granted for a ten (10) year term and, therefore, may not be exercised after the expiration of ten (10) years from the date that it is granted. This Option shall become exercisable at any time subject to the terms of this Agreement and applicable law.
(a)Vesting Schedule. This Option may be exercised in accordance with the following schedule: ______% of the Stock subject to the option shall vest _______________ after the Date of Grant, and ______% of the Stock subject to the option shall vest each _______________ thereafter. There shall be no proportionate or partial vesting in the period prior to each vesting date, and all vesting shall occur only on the appropriate vesting date. Should the Optionee be terminated (except for death or disability), then Optionee will forfeit all rights under this Agreement.
(b)Right
to Exercise. This Option shall be exercisable during the term of the Option, by the Optionee:
(i)While the Optionee is an employee of the Company, or within sixty (60) days of the termination of Optionee as an employee; provided that in the event Optionee’s employment by the Company is terminated because of disability, as that term is defined in Section 105(d)(4) of the Internal Revenue Code, as amended (the “Code”), the Option privileges, with respect to the shares purchasable by the Optionee as of the date that the Optionee terminated, may be exercised by the Optionee within one (1) year after the date of termination of the Optionee’s employment by the
Company. However, nothing contained within this statement shall be construed to extend the ultimate term of this Option beyond the period of time set out above in paragraph 2.
(ii)If the Optionee should die during the option period while employed by the Company, the option privileges may be exercised in full by the legal representative of the Optionee’s estate, or by the person or persons to whom the Optionee’s rights under the Option shall have passed by will or the laws of descent and distribution within one (1) year after the Optionee’s date of death. However, nothing contained within this statement shall be construed to extend the ultimate term of this Option beyond the period of time set out above in paragraph 2.
(c)Restrictions on Exercise. The
minimum number of shares for which this Option may be exercised is 100 shares. In addition, as a condition to the Optionee’s exercise of this option, the Company may require the person exercising this Option to execute any buy-sell agreement in effect between the Company and its shareholders and to make such representations or warranties to the Company as may be required by applicable law or regulation.
(d)Method of Exercise. This Option shall be exercisable by a written notice which shall:
(i)State the election to exercise the Option, the number of shares
in respect of which it is being exercised (which may be no less than 100 shares), the person in whose name the stock certificate for such shares of Stock is to be registered, the person’s address and social security number (or if more than one, the names, addresses and social security numbers of such persons);
(ii)Contain such representations and agreements as to the holder’s investment intent with respect to such shares of Stock as may be satisfactory to the Company’s counsel; and
(iii)Be signed by the person or persons entitled to exercise the Option and, if the Option is being exercised by any persons other than the Optionee,
be accompanied by proof satisfactory to counsel for the Company, of the right of such person or persons to exercise the Option.
In accordance with applicable federal, state and/or local tax withholding requirements, the Company shall withhold from Optionee’s compensation the required amounts. Optionee may satisfy any such withholding tax obligation by any of the following means or by a combination of such means: (i) tendering a cash payment, (ii) authorizing the Company to withhold shares of Stock otherwise issuable to the Optionee valued at Fair Market Value on Date of Exercise, or (iii) delivering to the
Company already owned and unencumbered shares of Stock valued at Fair Market Value on Date of Exercise.
(e)Payment of Option Price. Payment of the aggregate Option Price for the shares of Stock with respect to which an Option is being exercised shall be made by the Optionee in one of the following manners:
(i)Cash, certified or bank cashier check, or wire transfer, delivered with the notice of exercise as soon as practicable thereafter;
(ii)By delivery (including constructive delivery) to the Company of shares of Stock having an aggregate Fair Market Value on Date of Exercise equal to the aggregate Option Price; or
(iii)By
delivery on a form prescribed by the Committee of a properly executed exercise notice and irrevocable instructions to a registered securities broker approved by the Committee to sell shares of Stock and promptly deliver cash to the Company.
3.No transferability of Option. This Option may not be transferred in any manner otherwise than by will or the laws of descent and distribution and may be exercised during the lifetime of the Optionee only by the Optionee and after Optionee’s death by the legal representative of the Optionee’s estate or by the person or persons to whom the Optionee’s rights under the Option passed by will or the laws of descent and distribution. This Option shall not be pledged or hypothecated in any way and shall not be subject to executive, attachment
of similar process except with the express consent of the Committee.
4.Adjustments:
(a)Whenever a stock split, stock dividend or other relevant change in capitalization of the Company occurs, (1) the number of shares that can thereafter be purchased and the option price per share under each Option that has been granted and not exercised, and (2) the number of shares used in determining whether a particular Option is grantable thereafter shall be appropriately adjusted.
(b)In the event of the dissolution or liquidation of the Company, any Option granted under the Plan shall terminate
as of a date to be fixed by the Committee, provided that not less than 30 days’ written notice of the date so fixed shall be given to each Optionee and each such Optionee shall have the right during such period to exercise Optionee’s Option as to all or any part of the shares covered thereby, including shares as to which such Option would not otherwise be exercisable by reason of an insufficient lapse of time.
(c)Adjustments and determinations under this paragraph 4 shall be made by the Company’s Board of Directors, whose decisions as to what adjustments or determinations shall be made, and the extent thereof, shall be final, binding and conclusive.
5.Notices. Each notice relating to this Agreement shall be
in writing and delivered in person or by certified mail to the proper address, and shall be deemed to have been given on the date it is received. Each notice to the Company shall be addressed to it at its principal office, attention of the Secretary. Each notice to the Optionee or other person or person then entitled to exercise the Option shall be addressed to the Optionee or such other person or persons at the Optionee’s address set forth in the heading of this Agreement. Anyone to whom a notice may be given under this Agreement may designate a new address by written notice to that effect.
6.Benefits of Agreement. This Agreement shall inure to the benefit of and be binding upon each successor of the
Company. All obligations imposed upon the Optionee and all rights granted to the Company under this Agreement shall be binding upon the Optionee’s heir, legal representatives and successors. This Agreement shall be the sole and exclusive source of any and all rights which the Optionee, the Optionee’s heirs, legal representatives, or successors may have in respect to the Plan or any options or Stock granted or issued thereunder whether to the Optionee or to any other person.
2
7.Resolution of Disputes. Any dispute or disagreement which should arise under, or as a result of, or in any way relate to, the interpretation, construction
or applicability of this Agreement will be determined by the Board of Directors of the Company. Any determination made hereunder shall be final, binding, and conclusive for all purposes.
IN WITNESS WHEREOF, the Company and the Optionee have caused this Agreement to be executed effective as of the day, month and year first above written.
AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
By:
OPTIONEE:
3
Dates Referenced Herein and Documents Incorporated by Reference
